KIAA0825
GeneKIAA0825, the group of Armadillo like helical domain containing
Gene summary
No gene description available in the current model. Review primary literature for detailed gene function and characteristics.
- C5orf36
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~467.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032785
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0032785
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0032785
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0019673
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Musculoskeletal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to KIAA0825 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001145678.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 4 | 10 | |||
| missense | 1 | 2 | 53 | 7 | 2 | 65 |
| nonsense | 1 | 3 | 2 | 6 | ||
| start loss | 0 | |||||
| frameshift | 2 | 1 | 2 | 5 | ||
| splice donor/acceptor (+/-2bp) | 3 | 1 | 4 | |||
| Total | 4 | 9 | 58 | 13 | 6 | 90 |
Highest pathogenic variant AF is 0.00084038597
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001139150.1 | 19 | MANE Select | |
| Ensembl | ENSP00000506760.1 | 19 | MANE Select | |
| RefSeq | NP_001372641.1 | 19 | Standard | |
| RefSeq | NP_001372642.1 | 19 | Standard |
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000329378
- Coding exons
- 3
- Length
- 465639
- Individuals with no LoFs
- 125667
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 65
- Defined
- 125732
- p
- 0.000259
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.595 | 136 | 157 | 0.866 | 0.00000731 | 2165 |
| Missense (PolyPhen) | 28 | 39.379 | 0.71105 | 585 | ||
| Synonymous | 1.88 | 39 | 57.0 | 0.684 | 0.00000273 | 559 |
| Loss of Function | 0.121 | 13 | 13.5 | 0.964 | 6.35e-7 | 178 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00043 | 0.00043 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00028 | 0.00027 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00035 | 0.00035 | rare |
| South Asian | 0.00027 | 0.00026 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
Intolerance Scores
- RVIS EVS
- 0.24
- RVIS percentile EVS
- 68.98
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.114
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |